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Abstract
Background & aims
Breastfeeding is beneficial for mothers and infants. Underlying mechanisms and biochemi-
cal mediators thus need to be investigated to develop and support improved infant nutrition
practices promoting the child health. We analysed the relation between maternal breast milk
composition and infant metabolism.
Methods
196 pairs of mothers and infants from a European research project (PreventCD) were
studied. Maternal milk samples collected at month 1 and month 4 after birth were analysed
for macronutrient classes, hormone, and fatty acid (FA) content. Phospholipids, acylcarni-
tines, and amino acids were measured in serum samples of 4-month old infants. Associa-
tions between milk components and infant metabolites were analysed with spearman
correlation and linear mixed effect models (LME). P-values were corrected for multiple test-
ing (PLME).
Results
Month 1 milk protein content was strongly associated with infant serum lyso-phosphatidyl-
choline (LPC) 14:0 (PLME = 0.009). Month 1 milk insulin was associated to infant acetylcarni-
tine (PLME = 0.01). There were no associations between milk protein content and serum
amino acids and milk total fat content and serum polar lipids. Middle- and odd-chain FA% in
breast milk at both ages were significantly related to serum LPC and sphingomyelins (SM)
species in infant serum (all PLME<0.05), while FA% 20:5n-3 and 22:6n-3 percentages were
significantly associated to serum LPC 22:6 (PLME = 1.91×10−4/7.93×10−5) in milk only at
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month 4. Other polyunsaturated fatty acids and hormones in milk showed only weak associ-
ations with infant serum metabolites.
Conclusions
Infant serum LPC are influenced by breast milk FA composition and, intriguingly, milk pro-
tein content in early but not late lactation. LPC 14:0, previously found positively associated
with obesity risk, was the serum metabolite which was the most strongly associated to milk
protein content. Thus, LPC 14:0 might be a key metabolite not only reflecting milk protein
intake in infants, but also relating high protein content in milk or infant formula to childhood
obesity risk.
Introduction
Compared to infant formula feeding, breastfeeding (BF) is beneficial for mothers but particu-
larly for their infants, for example with respect to reduced risks for infections and, with less
clinical evidence to date, to later obesity and diabetes type 2, and promoting cognitive develop-
ment [1–4]. Promoting BF and an adequate BF duration is strongly recommended to support
child health and development [5]. Several studies have described the effects of maternal dietary
fat intake during lactation or milk fatty acid (FA) composition on offspring health, e.g. growth
[6–8], neurodevelopment [9, 10], and the risks of atopic diseases [11, 12] and allergy [13, 14],
but little is known on the direct effect on infant metabolism. The few association studies are
limited to fatty acid percentages (FA%) of maternal milk in relation to FA% in the infant blood
[12, 15–17]. Despite providing a potential mechanism linking milk and disease, those and
other studies are subject to limitations since they only describe FA% in infant serum and give
no information on the exact molecular structure of the affected lipid molecules. Having the
exact information on chemical bonds and backbones would enable to describe in details the
affected pathways. We have previously shown that dietary polyunsaturated FA (PUFA) pro-
vided to infants are dominately incorporated into phosphatidylcholine species containing an
ether bond (PCae) [18]. These lipids exhibit different chemical and physiological properties
compared to the major class of diacyl-linked phosphatidylcholines (PCaa) or triacylglycerols
[19], highlighting the importance to determine the molecular structure of the lipids.
One of the possibilities is to determine a wide range of small molecules (<1.5 kDa) with
mass spectrometry protocols. Its utilization for mechanistic studies in early life is increasing as
it offers the opportunity to determine alterations in the metabolism by environmental expo-
sures [20]. Kirchberg et al. demonstrated that the intake of infant formula (IF) with a high pro-
tein content resulted in increased amino acid (AA) and short chain acylcarnitine (AC) levels
in 6 month old infants as well as a saturation of branched-chain AA (BCAA) degradation path-
way and a decrease of FA oxidation [21]. In the same study, the lyso-phosphatidylcholine
(LPC) 14:0 was the only identified metabolite related to both early weight gain (WG) and obe-
sity risk at 6 years of age [22]. Other studies found aromatic amino acids (AAA) and BCAA to
be associated to obesity and insulin resistance development in adults, although huge contro-
versy exists regarding this topic, since studies in childhood could not reproduce this finding or
just found single AA, like tyrosine, being associated to insulin resistance [23–26].
The aim of this study was to analyse associations of maternal milk components at month 1
and month 4 to infant lipid and amino acids metabolism at 4 months of age. We used pre-
intervention samples from a European cohort for the study of coeliac disease (CD) prevention,
Impact of breast milk on infant metabolism
PLOS ONE | https://doi.org/10.1371/journal.pone.0197713 June 1, 2018 2 / 19
0031.71.5262806, email address m.l.
mearin_manrique@lumc.nl or the non-author
institutional e-mail address preventcd@lumc.nl. Or
to the coordinator of Early Nutrition: Prof. Dr. B.
Koletzko, Dr. von Hauner Children’s Hospital, Univ.
of Munich Medical Center, Campus Innenstadt
Lindwurmstr. 4, D-80337 Muenchen, Germany.
Phone number 0049.8944005 2826, email address
Berthold.Koletzko@med.uni-muenchen.de or the
non-author institutional e-mail address
metabolomics@med.lmu.de.
Funding: This work was financially supported by
the Commission of the European Communities, the
6th Framework Programme, contract FP6-2005-
FOOD-4B-36383–PREVENTCD, the 7th Framework
Programme, contract FP7-289346-EARLY
NUTRITION, the European Research Council
Advanced Grant ERC-2012-AdG – no.322605
META-GROWTH, the Azrieli Foundation, Deutsche
Zo¨liakie Gesellschaft, Eurospital, Fondazione
Celiachia, Fria Bro¨d, Instituto de Salud Carlos III,
Spanish Society for Pediatric Gastroenterology,
Hepatology, and Nutrition, Komitet Badań
Naukowych (1715/B/P01/2008/34), Fundacja
Nutricia (1W44/FNUT3/2013), Hungarian Scientific
Research Funds (OTKA101788, NKFI120392 and
TAMOP 2.2.11/1/KONV-2012-0023), Stichting
Coeliakie Onderzoek Nederland, Thermo Fisher
Scientific, and the European Society for Pediatric
Gastroenterology, Hepatology, and Nutrition. This
manuscript does not necessarily reflect the views
of the Commission and in no way anticipates the
future policy in this area. The funders had no role in
study design, data collection and analysis, decision
to publish, or preparation of the manuscript. The
authors declare to have no conflict of interest.
Competing interests: The authors report no
conflict of interest with respect to the study
reported.
the PreventCD study [27]. We have previously shown that infant metabolites were not altered
due to later CD development or maternal human leukocyte antigen status [28]. Therefore, we
could use this study and its unique bio-sample availability to depict how early and late mater-
nal milk composition influence infant metabolites.
Material and methods
Study design
This is a secondary analysis on 196 mother/infant pairs from PreventCD. PreventCD is a pro-
spective, double-blind, placebo-controlled, randomized, dietary-intervention study in children
with high risk for development of CD [27, 29] conducted in Croatia, Germany, Hungary, Israel,
Italy, the Netherlands, Poland, and Spain. Infants between 0–3 months of age were recruited if
they had at least one first-degree family member with CD confirmed by small-bowel biopsy,
and if they were HLA-DQ2 or HLA-DQ8 positive or carried the allele DQB102. Since later CD
development and HLA-risk group assignment had no influence on the serum metabolites [28]
and the intervention was applied after blood withdrawal, these variables were not investigated
in the present study.
The study was registered at ISRCTN on February 26th, 2007 and the first / last child was
included on May 26th, 2007 / September 25th, 2010, respectively. Prematurity or syndromes
associated with an increased risk of CD, such as trisomy 21 or Turner’s syndrome, were exclu-
sion criteria. Between 4 and 6 months of age, infants received either 200 mg of vital wheat glu-
ten mixed with 1.8 g of lactose) or 2g of lactose per day. All infant serum samples used for the
present study were withdrawn before this intervention started. Data collection and anthropo-
metric measurements were performed as previously reported [27].
The study was approved by the medical ethics committee at each participating centre and
complied with Good Clinical Practice guidelines. The study was conducted according to the
Declaration of Helsinki. The parents of all children provided written informed consent for the
study. The PreventCD Current Controlled Trials number is ISRCTN74582487. The authors
confirm that all ongoing and related trials for this drug/intervention are registered. Ethical
committee review boards (with respective date of ethical approval): Commissie Medische
Ethiek LUMC, Leiden, the Netherlands (December 1st, 2006); Comitato Etico, Universita degli
studi di Napoli ‘Fedrico II’, Naples, Italy (October 12th, 2006); Komisja Bioetyczna przy Wars-
zawskim Uniwersytecie Medycznym, Warsaw, Poland (July 17th, 2006); Provecto de Investiga-
cion, La Paz, Madrid, Spain (November 7th, 2006); Instituto de Invest Investigacion, La Fe,
Valencia, Spain (December 19th, 2006); Rabin-Schneider IRB, Tel Aviv, Israel (October 4th,
2006); Etičkog povjerenstva. Zagreb, Croatia (February 17th, 2006); Institutional Research Eth-
ics Committee, Heim Pal Childrens Hospital, Budapest, Hungary (March 6th, 2007); Comite
d’Etica d’Investigacio Clinica, Reus, Spain (February 22nd, 2007); Ethikkomimision LMU,
Munich, Germany (May 21st, 2007).
Sample collection
Blood samples were collected from the infants at the 4-month visit. After collection, the blood
was centrifuged and the frozen serum samples were stored at -20˚C. Subsequently, the serum
samples were aliquoted and sent to the central laboratory for antigliadin antibody (AGA) and
transglutaminase type2 antibody (TG2A) determinations. The rest sera was transported and
re-stored at -20˚C at the sera bank of the project at the department of Immunohematology
and Blood Transfusion, Leiden University Medical Center, Leiden. Samples chosen for this
study were transferred on dry ice to LMU Munich and stored at -80˚C until mass spectrome-
try-based analysis of metabolites.
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Maternal milk samples, used in the presented analysis, were collected at visits 1 and 4
months after birth. Mothers expressed their milk manually or by pump once a month during
the first six months after birth. No further specification to collect fore- or hind-milk sampling
and time of day were given to the mothers. The milk samples were frozen at -20˚ C at home,
transferred to the hospital on ice and stored at—80˚ C. Milk samples for the presented analysis
were aliquoted (1–2 ml), transferred on dry ice to LMU Mu¨nchen and stored at -80˚C until
analysis.
Selection of samples. In order to obtain complete sample sets, only those mother/infant
pairs were included in this sample analyses who had both an infant serum sample at month 4
and at least 1 corresponding maternal milk sample at month 1 or month 4 available.
Breast milk analysis
Maternal milk samples were analysed for macronutrients classes (fat, protein) as well as FA%
and hormones (insulin, IGF-II, adiponectin, leptin).
For fat analysis, milk samples were diluted 1:3 with water and sonicated and heated to 40˚
C prior to analysis. Total fat was measured via mid-infrared spectroscopy with a MIRIS
Human Milk Analyzer (MIRIS HMA, Miris AB, Uppsala, Sweden) [30]. Protein content was
measured with an adapted Bradford method as described previously [31]. FA composition,
using 20 μl of milk, was analysed by gas chromatography (GC) as previously described [32].
The lipid bound FA were converted with acidic catalysis into FA methyl esters and extracted
into hexane prior to GC analysis. Molecular percentages of 35 FA with 8 to 24 carbon atoms
were determined (FA%).
Breast milk total adiponectin concentration was measured with a commercially available
ELISA kit (Biovendor RD191023100 High Sensitivity Adiponectin, Brno, Czech Republic).
50 μl skimmed milk were diluted 1:3 with the dilution buffer provided with the test kit, and the
procedure followed the protocol of the manufacturer. Leptin concentrations in skimmed milk
were determined with an ELISA (human leptin; R&D Systems, Minneapolis, MN; Catalogue
Number DLP00). 100 μl of skim milk were diluted 4-fold and the further analysis was per-
formed according to the manufacturer‘s instructions.
Insulin concentrations were measured with the Mercodia Insulin ELISA kit 10-1113-01
(Mercodia, Uppsala, Sweden) from 25 μl undiluted, skimmed milk. The assay procedure was
performed according to the protocol of the manufacturer. IGF-II was determined with a radio-
immunoassay from 30 μl full fat milk by Mediagnost (Reutlingen, Germany) using the R-30
IGF-II RIA kit according to the protocol of the manufacturer.
Infant serum metabolites
The infant metabolites were quantified as described previously [28]. As these are targeted pro-
tocols, we used internal and external standards for calibration and quantification of the tar-
geted metabolites. A labelled amino acid standards set (NSK-A), 15N2 L-Asparagine (NLM-
3286), Indole-D5 L-Tryptophan (DLM-1092), D3-Carnitine C2 (DLM-754), D3-Carnitine C8
(DLM-755), D3-Carnitine C16 (DLM-1263), 13C6-D-Glucose (CLM-1396), (all Cambridge
Isotope Laboratories), 1-tridecanoyl-2-hydroxy-sn-glycero-3-phosphocholine (855476P), and
1,2-dimyristoyl-sn-glycero-3-phosphocholine (850345P), (both Avanti Polar Lipids) were used
as internal standards. For calibration, we used a amino acid standard mixture (A9906) from
Sigma Aldrich, L-Asparagine anhydrous (11150) from Fluka, L-Glutamine (G3126) from
Sigma Aldrich and a control plasma (10282) from Recipe.
For amino acid (AA) analysis, 10μl of serum was used for derivatization to AA butylester,
which were separated by ion-pair liquid chromatography (LC). The LC system (Agilent,
Impact of breast milk on infant metabolism
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Waldbronn, Germany) was coupled to a tandem mass spectrometer (MS/MS, QTRAP4000,
Sciex, Darmstadt, Germany) with an atmospheric pressure chemical ionization source operat-
ing in positive ionization mode. The MS was run in positive Scheduled Multiple Reaction
Monitoring (SMRM) mode. For quantification of polar lipids, 10μl serum were diluted with
methanol and supernatants were injected into the LC-MS/MS system which was used as flow-
injection analysis. The MS was run in MRM mode in both positive and negative ionization
mode. We determined free carnitine, acylcarnitines (AC), lysophosphatidylcholines (LPC),
diacyl-phosphatidylcholines (PCaa), acyl-alkyl-phosphatidylcholines (PCae), and sphingo-
myelines (SM). The structures of the hydrocarbon chains of the polar lipids are indicated by
the denotation Cx:y where x and y denote the length of the hydrocarbon chain and the number
of double bonds, respectively. ‘a’ indicates that the chain is bound via an ester bond to the
backbone, while ‘e’ indicates binding by an ether bound. ‘OH’ stands for an additional
hydroxyl group and ‘DC’ for two carboxyl groups in the molecule.
During the quantification processes, the samples of the study centres were randomly dis-
tributed across the batches. The entire analytical process was post-processed by the software
Analyst 1.5.1 and R 3.2.1. All metabolite concentrations are reported in μmol/L.
Statistics
Using six aliquots of one quality control (QC) samples that were measured along with the
serum samples in each batch, we selected the metabolites for analysis. If the coefficient of varia-
tion of the QC samples was <30%, then the metabolite was included in the analyses. The batch
effect was removed in the statistical models (see below). Afterwards, outliers (defined a mea-
surement whose absolute concentration is over one standard deviation (SD) away from its
nearest neighbour) were excluded from the data analysis.
For the analysis of the effect of month 1 milk on the infant serum at 4 month, we included
only milk samples that were (i) frozen during transport, and (ii) collected between infant age 6
and 47 days.
For the cross-sectional analysis between month 4 milk and the infant serum at 4 month, we
included only milk samples that (i) were frozen during transport, (ii) have been collected
between infant age 106 and 134 days and (iii) that were collected before or at most three days
after the corresponding infant blood sample was collected.
Associations between milk components and infant metabolites were analysed with spear-
man correlation (ρ) and linear mixed effect models (LME) with the milk compound as inde-
pendent variable, adjusted for infant sex, breastfeeding status at blood withdrawal (exclusively
BF yes/no), and the infant’s age at blood withdrawal. Random intercepts were modelled for
batch number and study centre. Models were run on available cases and sample sizes are
reported for each association. P-values were corrected (PLME) for multiple testing using Bon-
ferroni’s methods, this is by dividing the p-value with number of metabolites (n = 184). A
PLME < 0.05 is considered as statistically significant. If only the uncorrected p-value was
<0.05, we speak of a trend. We additionally report the estimate of the LME (BLME). For visuali-
zation, circled Manhattan plots and heatmaps were used. The Manhattan plots were used for
milk hormones and macronutrient classes associations to serum metabolites, which were
arranged in a circle. Negative log10-transformed uncorrected p-values were plotted for associa-
tions between single metabolites and hormones/macronutrients classes with higher values
presenting stronger associations in the outer part of the circle. The Bonferroni corrected sig-
nificance threshold is indicated by the black outer circle. Heatmaps were utilized to visualize
associations between milk FA% (y-axis) and single metabolites (x-axis). Spearman correlation
coefficients were plotted with red indicating negative ρ and green positive ρ.
Impact of breast milk on infant metabolism
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As milk components as well as serum metabolites may strongly correlate with each other,
we performed sensitivity analyses by manually checking the effects in LME: For serum metab-
olites that were associated either to more than one milk macronutrient classes/hormone or to
at least one milk macronutrient classes/hormone and milk FA%, we regressed the serum
metabolite (outcome) on the respective macronutrient classes, hormone or fatty acid variables.
We adjusted each model for infant sex, breastfeeding status at 4-month blood withdrawal
(exclusively BF yes/no), and the infant’s age at blood withdrawal. Random intercepts were
modelled for batch number and study centre. This model was additionally calculated with
interaction effect between the determinants. Multicollinearity was checked using variance
inflation factors (VIF). A VIF of 4 was considered as indicator for multicollinearity.
Additionally, a subgroup analysis was conducted on infants who were exclusively breastfed
until the 4-month blood withdrawal. For this analysis, all statistical models mentioned above
were performed, again.
Results
Of 944 children in the PreventCD-cohort, 196 complete mother/infant pairs with complete
sample sets were analysed (Fig 1). Their characteristics are described in Table 1. Hundred
Fig 1. CONSORT flow diagram. Of 944 children in the PreventCD-cohort, 196 complete mother/infant pairs with
complete sample sets were analysed. 136 pairs were studied for the associations between month 1 breast milk
composition and infant serum metabolites at age of 4 months and 137 were studied for the associations between month
4 breast milk composition and infant serum metabolites at age of 4 months. 87 were studied at both time points.
https://doi.org/10.1371/journal.pone.0197713.g001
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thirty-six pairs were studied for the associations between month 1 breast milk composition
and infant serum metabolites at age of 4 months. Hundred thirty-seven pairs were studied for
the associations between month 4 breast milk composition and infant serum metabolites at age
of 4 months. Seventy-eight pairs were studied at both time points. Hundred eighty-four serum
metabolites were quantified in infants aged 4 months. Analysis was conducted in all children
(including exclusively and non-exclusively BF at 4 month) and in children who were exclu-
sively breastfed at 4 months. We observed no difference between these analyses and will pres-
ent the analysis on all children (S1 Fig).
Breast milk macronutrient classes
Results (Spearman’s ρ and results of LME) for maternal milk macronutrient classes association
to infant serum are shown in Fig 2 and S1 Table. Milk protein showed only one significant
association. Month 1 milk protein content was strongly associated with LPC 14:0 in the
infant blood serum at 4 months of age (ρ = 0.291 BLME = 1.4, PLME = 9.0 x10-3). Only when
Table 1. Characteristics of the infant/mother pairs studied with breast milk samples available at month 1 and month 4.
Month 1 BM (n = 136) Month 4 BM (n = 137)
N Mean ± SD or n Mean ± SD or n
Sex (Female) 136 69 137 61
Age mother at birth (years) 132 33.6 ± 3.57 132 33.4 ± 3.87
Age infant at serum sampling (days) 136 120.3 ± 7.45 137 123.1 ± 5.59
Age infant at milk withdrawal (days) 136 27.8 ± 8.50 137 118.3 ± 5.65
Birthweight (kg) 136 3.4 ± 0.47 136 3.3 ± 0.43
Exclusively breastfed 4 month 136 119 137 116
Country of Study Centres 136 137
Netherlands 30 23
Italy 9 3
Spain 32 40
Hungary 30 37
Germany 35 34
https://doi.org/10.1371/journal.pone.0197713.t001
Fig 2. Associations between breast milk macronutrient classes and hormones to infant serum metabolites at 4 months of age.
Breast milk components were measured at month 1 (a) or month 4 (b). Negative log-transformed P-values are plotted for each
metabolite arranged by metabolite group and species. Higher values represented in the outer circles present a higher association
between metabolite and predictor. P-values were calculated by linear regression models with the milk compound as independent
variable, adjusted for infant sex, breastfeeding status at 4-month blood withdrawal (exclusively BF yes/no), and the infant’s age at
blood withdrawal. Random intercepts were modelled for batch number and study centre. P-values were corrected (PLME) for
multiple testing using Bonferroni’s methods, this is by dividing the p-value with number of metabolites (n = 184).
https://doi.org/10.1371/journal.pone.0197713.g002
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considering the unadjusted significance threshold, several other LPC in infant serum tended
to be positively associated with month 1 milk protein content: LPC 15:0, 16:1, 18:1, 18:2, 18:3,
20:3, 20:4, 22:5, and 22:6 (ρ = 0.077–0.252). An association between serum AA to month 1 or
month 4 milk protein was not observed.
Total fat content in milk was not significantly associated to serum metabolite profile at
either month after correction for multiple testing.
Breast milk fatty acid composition
Percentages of maternal milk FA were correlated and associated to the several lipid derivate
metabolites in the serum of the infants aged 4 months (Fig 3, S2 Table). Particularly, month 1
and month 4 middle- (C10-C14) and odd-chain (C13, C15, C17) FA% in milk showed signifi-
cant associations.
Month 1 middle-chain FA% (chain-length of 10 to 14 carbon atoms) in milk were signifi-
cantly correlated to LPC 14:0 in infant serum, the shortest LPC measured, as well as to SM and
PC species, in particular to those with 30 to 34 carbon atoms in infant serum (ρ = 0.328–
0.455). However, in the adjusted LME, only FA% 14:0 in month 1 was found to be significantly
Fig 3. Correlations between breast milk fatty acids percentages to infant serum metabolites at 4 months of age.
Breast milk components were measured at month 1 (a) or month 4 (b). Spearman correlation coefficients are plotted
for each metabolite arranged by metabolite group. AA, amino acids; Carn, acylcarnitines; LPC,
lysophosphatidylcholines; PC aa, diacyl-phosphatidylcholines; PC ae, acyl-alkyl-phosphatidylcholines SM,
sphingomyelins.
https://doi.org/10.1371/journal.pone.0197713.g003
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associated to LPC 14:0 in infant serum (BLME = 15.0, PLME = 4.4 x10-2). Month 1 odd-chain FA
% in milk were correlated and associated to LPC 15:0 and 17:0 (ρ = 0.331–0.380, PLME =
2.6x10-6–4.6x10-4) and SM species with an odd numbered carbon chain length (ρ = 0.322–
0.499, PLME = 9.6x10-5–4.6x10-2) in spearman correlation and LME associations studies. The
FA% 18:2n-6, 20:2n-6, 22:4n-6 and 22:5n-6 in month 1 milk were negatively correlated to AC
18:1 (ρ = -0.363-(-0.331)). No significant association for AC with month 1 milk component
were observed in the LME.
Month 4 middle-chain FA% 12:0 and 14:0 in milk were correlated to LPC 14:0, and all mid-
dle-chain FA% were correlated and associated to PC and SM with 30–32 Carbon atoms (ρ =
up to 0.488, PLME = down to 3.75x10-11) in infant serum. Month 4 odd-chain FA% in milk
were related to LPC 15:0 and 17:0 and SM species with an odd-chain number of carbon atoms
in spearman correlation and LME associations studies (ρ = up to 0.504, PLME = down to
3.68x10-8). Month 4 FA% 18:0, 18:1n-7, 20:2n-6, and 22:4n-6 showed negative correlations to
LPC, SM and PC (ρ = down to -0.475) but fewer significantly negative associations in the
LME. Month 4 FA% 20:5n-3, 22:5n-3 and 22:6n-3 in milk were correlated and associated to
LPC 22:6 (BLME = 906.0/876.5/353.0, PLME = 2.21x10-4/2.20x10-2/9.55x10-5, respectively) and
20:5n-3, and 22:6n-3 were significantly associated to PCaa 38:6, 42.4, PCae 38:0, and SM 42.6.
The FA% 18:2n-6, 20:2n-6, 20:3n-6, 22:4n-6 and 22:5n-6 in month 4 milk were negatively
correlated to several AC (ρ = down to -0.544), while 14:1, 15:0. 15:1, 16:0 and 18:2tt showed
positive correlations (ρ = up to 0.424). No significant association for AC with month 4 milk FA
% were observed in the LME.
Breast milk hormones
The determined maternal milk hormones showed only weak association with infant serum
metabolites (Fig 2, S3 Table). Only the associations between month 1 milk insulin and acetylcar-
nitine (AC 2:0) were significant after correction for multiple testing (ρ = 0.242, BLME = 0.056,
PLME = 0.009). In general, several serum phospholipids tended to be positively associated to
month 1 milk insulin, if correction for multiple testing was ignored. Month 1 and month 4 milk
IGF-2, and adiponectin and month 4 milk leptin showed no significant associations.
Correlation of breast milk fatty acids
Respectively at month 1 and month 4, saturated middle-chain FA% in breast milk correlated
strongly positively with each other and trans-FA% 16:7t and 18:2tt, but negatively with FA%
18:1n-7, 18:1n-9 and n-6 FA% (S1 Fig). Maternal milk odd-chain FA% were also strongly cor-
related. FA% 14:1 was correlated to all FA% with 15, 16, or 17 carbon atoms, but not to the sat-
urated milk middle-chain FA% at both time points, respectively. Milk n-6 FA% showed
positive correlations among each other, like the n-3 FA% 20:5 and 22:6.
Sensitivity analysis
Only one infant serum metabolite was affected by several breast milk nutrients. We ran LME
models with interaction effects to investigate these associations closer.
Serum LPC 14:0 was associated to month 1 milk protein and month 1 milk FA% 14:0. In the
combined multivariable model (LPC 14:0 ~ month 1 milk protein + month 1 milk FA% 14:0
+ confounders), only month 1 milk protein (BLME = 1.27, PLME = 3.1 x10-2) remained statisti-
cally significant, but month 1 milk FA% 14:0 was borderline significantly associated to LPC
14:0 (BLME = 13.5, PLME = 0.08). No multicollinearity was observed (VIF = 1.01). The effects of
month 1 milk protein and FA% 14:0 on serum LPC 14:0 were of equal magnitude: An increase
of one standard deviation of month 1 milk protein would results in an increase of 0.28 μM of
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serum LPC 14:0, while an increase of one standard deviations of month 1 milk FA% 14:0
would results in an increase of 0.26 μM of serum LPC 14:0 (meanLPC 14:0 = 1.66 μM, sdLPC 14:0
= 0.91 μM). Explained variance by all independent variables together was R2 = 75%. No signifi-
cant interaction between month 1 milk protein and month 1 milk FA% 14:0 was observed
(PLME = 0.61). Both components did not correlate either (ρ = 0.080).
Discussion
We studied the association of components of human breast milk collected one or four months
after birth with the infant serum metabolites at 4 month of age. Infant feeding is considered to
play a crucial role in the later development of non-communicable disease. Studies collecting a
large number of breast milk samples and corresponding infant blood samples offer an exclu-
sive opportunity to elucidate the effect of milk components. We used maternal milk and infant
serum samples available from the PreventCD study to assess the effects of milk on infant
metabolites in mother/infant pairs in a longitudinal (month 1 milk ~ month 4 infant metabo-
lites) and a cross sectional approach (month 4 milk ~ month 4 infant metabolites). In the longi-
tudinal approach, the association of protein breast milk content and LPC 14:0 is striking.
While fat and hormone breast milk content showed only a very weak effect on the infant
metabolites, the milk FA% showed strong associations to infant serum phospholipid species,
but in a PL species specific manner.
Milk macronutrient classes and hormones
Month 1 maternal milk protein was strongly associated to month 4 infant serum LPC 14:0,
and, to a lesser extent, to other LPC. However, this effect could not be replicated for month 4
breast milk. Probably the much higher protein concentration in milk shortly after birth has a
stronger and longer effect on the serum LPC, compared to the reduced milk protein amount
later during lactation [33]. In the European Childhood Obesity Programme (CHOP) study,
infant serum LPC 14:0 at 6 month of age was significantly associated with both rapid weight
gain in the first 6 months of life as well as overweight/obesity at 6 years [22]. In the CHOP
study, infants were randomly allocated to receiving an IF containing conventionally high pro-
tein (HP) or an IF with reduced protein content. In this context, when referring to the only
published study having found LPC 14:0, one has to note that IF in the first month of life is not
following the natural decline of protein in milk. It may thus have much stronger effects on
LPC 14:0, and the potential adverse effects of the LPC. The metabolites in infant blood which
were expected to be influenced by higher protein intake and to affect infant metabolism were
BCAA. However, these AA were not related to maternal milk protein in the presented study,
not even by trend. Thus, LPC 14:0 seems to present a more reliable candidate for the program-
ing mechanism linking early protein intake and childhood obesity risk. But how is protein in
milk or IF affecting this metabolite? To answer this question, mechanistic studies are needed.
We can only speculate on the pathways. There is a general effect of month 1 breast milk protein
on LPC, since the five strongest associations of month 1 milk protein to month 4 infant metab-
olites are all with LPC (14:0, 18:2, 16:1, 20:4, 22:6). LPC are a product of hydrolysis of phospha-
tidylcholines by phospholipases [34] or endothelial lipases [35], hepatic secretion [36] or
lecithin cholesterol acyltransferase (LCAT). LCAT, which produces LPC and cholesterol esters
by transferring a FA from a PC to free cholesterol, is the dominating enzyme for LPC forma-
tion [37]. Human LCAT preferentially transfers the FA at sn-2 position of PC to cholesterol
[38], although the sn-1 position is utilized in case the sn-2 chain is very long (C20:4, C22:6)
[39]. Thus, LPC in the infant serum are most likely a product of LCAT activity which is also
regulated by the diet [40–43]. In general, lower protein intake results in lower LCAT activity
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[44, 45] which supports our findings. Thus, the association of milk protein to LPC is not sur-
prising, but the accentuated relation to LPC 14:0 is still posing challenges. Maternal milk FA%
14:0 did not correlate with milk protein concentration and both components showed no inter-
action effect in a multivariable model. This fact points towards an independent effect of milk
protein on serum LPC 14:0. Potentially, breast milk protein is acylated with FA 14:0 to a higher
degree. Since this would only affect small concentrations, an effect of milk protein on the
metabolism of middle-chain fatty acids in infants is more reasonable. Dietary protein was
shown to increase the expression of lipogenic enzymes in the muscle of piglets [46, 47], while a
high protein diet decreased lipogenic activity in adipose tissue of pigs [48]. Whey protein and
soy protein suppressed hepatic fatty acid synthesis and accelerated fat oxidation in rodents [49,
50]. Thus, dietary protein seems to have a tissue-specific effect on fat and FA metabolism—
additionally depending on the quality of the protein. Drawing conclusion from our trial is
challenging in this context since we measure blood metabolites, influenced by metabolism of
different tissues. Another challenge in the interpretation represents our finding that the LPC
14:0 concentration in infant serum 4 month after birth was influenced by month 1 maternal
milk protein only and not by month 4 milk protein. Having speculated on the mechanisms
provoking the high infant LPC 14:0 levels, the question on what potentially makes this metabo-
lite deleterious now imposes itself. The degradation product of LPC, lysophosphatidic acid
(LPA) [37], is a lipid mediator acting via G-protein coupled receptors [51]. LPA was shown to
impair glucose homeostasis and inhibit insulin secretion [52, 53] and is associated to inflam-
mation processes [54, 55] and obesity [56].
Next to the month 1 protein to serum LPC 14:0 association, the association of month 1
insulin to serum acetylcarnitine was the only other significant relationship found between
breast milk macronutrient classes or hormones and any infant metabolite. In general, insulin
suppresses hepatic acetyl-CoA production [57], but in this case the situation is different since
we have to speculate about potential effects of breast milk insulin. Once taken up by the infant,
breast milk insulin has to survive the gastrointestinal digestions, but orally administered insu-
lin was found to be rapidly destroyed by trypsin activity in adults [58]. Probably, trypsin activ-
ity is reduced in infants and insulin may reach the systemic circulation in infants. Also,
protease inhibitors α1-antitrypsin and α1-antichymotrypsin are present in human breast milk
and decline throughout lactation [59]. However, no data is available about trypsin activity on
insulin in infants or children. Thus, it is difficult to speculate about milk insulin effects. A
recent study found that breast milk insulin was associated with lower infant weight [60]. There
results might fit our findings: if milk insulin somehow induces fat oxidation, as indicated by
higher acetylcarnitine levels, this might lead to lower infant weight. This however is just a
weak hypothesis, since serum insulin usually support fat deposition rather than oxidation.
Another explanation could be a strong relation between maternal and infant blood insulin, by
genetic background. Maternal blood insulin would effect maternal BM insulin, and infant
blood insulin has effects on energy metabolism.
Regarding the weak associations between macronutrients classes (fat, protein) as well as
milk hormones (insulin, adiponectin, leptin, IGF-II) and the infant metabolites, it is particu-
larly striking that milk protein content and serum essential AA as well as milk fat content and
serum phospholipids did not correlate significantly. Since we have no information about the
amount of milk intake of the infants, it may be of more importance to determine the amount
of breast milk macronutrients intake rather than their concentrations in the milk. One can eas-
ily assume that lower fat and protein results in lower caloric content of breast milk. As shown
previously [61], this lower caloric amount is compensated by higher milk intake of the infant.
Thus, breast milk macronutrient composition is a weak proxy for the actual macronutrient
amount reaching the infant gut and affecting the infant metabolism and growth.
Impact of breast milk on infant metabolism
PLOS ONE | https://doi.org/10.1371/journal.pone.0197713 June 1, 2018 11 / 19
Breast milk FA%
When investigating the FA species, the FA% gain importance as they reflect the composition
of the FA in the milk. The month 1 and month 4 FA% in breast milk were strongly related to
infant metabolites and especially to the PL. These relative compositions of milk FA were stron-
ger associated to serum PL compared to the associations of total milk fat to PL, probably
because the effect of the breast milk composition is independent of the absolute intake of FA.
Odd-chain FA%, middle-chain FA% and, to a lesser extent, n-3 FA% in milk showed strong
associations to infant PL. The stronger correlation of milk n-3 FA% to infant serum metabo-
lites compared to milk n-6 FA% [15] in month 4 and the missing associations of long-chain
saturated and mono-unsaturated FA% in milk to infant FA% were described previously [12,
13]. Kankaanpa¨a¨ et al showed that serum lipid fatty acids in atopic infants did not correlate
with those in maternal breast milk [12], but other trials also report strong correlations between
milk trans-FA%, n-3 FA%, and n-6 FA% and infant serum FA% of PL [12, 17, 62]. Jonsson
et al. recently showed that maternal dietary intake of oily fish correlated with milk FA% 20:5n-
3 [13]. FA% 20:5n-3 was further correlated to infant serum FA% 20:5n-3 at four months after
birth which was found to be lower in infants developing allergy until the age of 3 years in the
same study [13]. However, these previous trials analysed FA% in the blood of infants and not
molecular species like we did with our mass spectrometry-based approach. The associations
found in the present study were rather not an overall effect on all PL species, but affected spe-
cific structures in the PL molecules. This finding would probably not have been found when
analysing FA% in blood of infants, since our measurements capture FA derived from PL. The
main class of PL are PCaa. In our study, PCaa only showed few associations to milk FA %.
Odd-chain FA% in milk collected at month 1 and month 4 were mainly associated with odd-
chain LPC and SM in infant serum. Middle-chain LPC were only associated to middle-chain
FA% of maternal milk collected at month 1, but not at month 4. In contrast, middle-chain FA%
of maternal milk collected at month 1 and month 4 were associated to PC and SM containing
middle-chain fatty acids. The more prominent association of middle-chain milk FA% to infant
PL compared to the other milk FA% is most likely due to the better resorption of middle-chain
FA [63].
Interestingly, we also observed negative associations between breast milk FA% and infant
serum metabolites. In particular n-6 FA% in and month 4 milk were negatively associated to
LPC, PC, and SM species probably not containing the corresponding FA. Usually, the sn-1
position of PCaa is esterified with a saturated or monounsaturated species, and the sn-2 is
occupied by a FA with higher unsaturation [64]. The observed negative associations thus speak
for a competitive mechanism for incorporation of FA into PL. However, it has to be noted that
milk FA% which were negatively related to infant serum PL did not show any positive associa-
tions to any PL species which might contain this FA. Hence, it is likely that these FA are incor-
porated in other lipids like triacylglycerols or cholesterol esters rather than PL. Kankaanppa¨a¨
et al. showed that milk FA% correlated mainly with cholesterol ester FA% and triacylglycerol
FA%, and not PL, in the infant serum [12]. In the present study, we did not measure choles-
terol esters or triacylglycerols, hence we are not able to verify the previous finding. Further-
more, we have shown that breast milk n-6 FA% at month 1, but in particular in month 4, were
negatively associated to serum long-chain AC levels in 4 months old infants. Since AC are
formed at the outer mitochondrial membrane to transport acyl chains into the mitochondria
for oxidation, one could speculate about effects of dietary n-6 FA on fatty acid oxidation.
Recent publications report an influence of dietary n-3 FA on fat oxidation [65, 66], but it is
suggested that a reduction in dietary n-6/n-3 FA ratio is associated with higher fat oxidation
[67] which is not in line with our results.
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Regarding n-3 FA%, although the spearman correlation showed significant associations for
some PCae species, in the adjusted models we only observed a positive effect on serum LPC
22:6. We previously described that 22:6n-3 in infant formula is preferentially incorporated into
PCae species [18], possibly because PCae provide a unique structure to protect 22:6n-3 from
oxidation and transport to the tissue [19]. When it comes to brain supply with 22:6n-3, MFSD2,
the transporter of LPC 22:6, seems to play a crucial role. In a mouse model, a MFSD2 deficiency
was related to lower brain 22:6n-3 levels and cognitive deficits [68]. Thus, in contrast to other
PL LPC 22:6 exhibits a beneficial role, and represents a potential pathway linking breastfeeding
and brain development. However, no explanation can be given why maternal milk FA% 22:6n-
3 as well as odd-chain and middle-chain FA% are closely related to LPC and weaker to the PC.
Our study generates hypotheses guiding opportunities for future research. The unique
design of the present study with its large number of mother/infant pairs with available milk
and serum samples gives specific advantages in attempts to further elucidate the possible
mechanisms of the beneficial effects of breast milk components and composition. To our
knowledge we are the first to investigate the influence of maternal milk on a wide range of
metabolites in the infant serum to this extent and in this much detail. Our targeted mass spec-
trometry-based platform depicts a comprehensive and representative number of metabolites
involved in the lipid- and energy metabolism. However, an even larger sample number would
have given us the opportunity to even dive deeper into the mechanisms initiated, like stratifica-
tion for sex or analysis of the effect of breastfeeding duration.
The biggest challenge was the missing data about the amount of breast milk intake of the
infant which may possibly have led to some missing or weak associations. Thus, we strongly
recommend collecting this variable in future trials with breastfed infants. Furthermore, the
milk samples were not completely standardized to collection of fore- or hint-milk or daytime,
which is challenging since FA composition varies over the course of the day [69]. We also have
variation in frequency of breastfeeding, parity, maternal diet and age, and the technique used
to pump milk (manually or by pump). Additionally, the age of the infant at the “month 1
breast milk” sampling has a huge variation (6 to 47 days), which will strongly affect the milk
composition [70, 71]. In the presented results, we reduced this influence by adjusting for sam-
pling date. All these factors potentially influence our results in particular given the small num-
ber of relevant findings of our work. We strongly recommend standardized collecting
variables in future trials with breastfed infants.
Conclusion
The composition of the measured human milk components has only a modest influence on
the infant’s metabolite serum levels at 4 month of age. We speculate that the amount of milk
intake and the absolute intake of specific metabolites may have a more important influence on
the infant’s metabolism, and that infants may be able to adjust their milk intake according to
milk composition. However, especially serum LPC correlate by breast milk FA% and, most
surprisingly, milk protein content in early lactation. LPC 14:0 was the most associated serum
metabolite by milk protein content and was found to be positively associated to growth and
obesity risk in previous studies. Thus, LPC 14:0 might be a key metabolite not only reflecting
milk protein intake in infants but also relating high protein content in breast milk or infant
formula to childhood obesity risk.
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Breast milk components were measured at month 1 (a) or month 4 (b). Negative log-trans-
formed P-values are plotted for each metabolite arranged by metabolite group and species.
Higher values represented in the outer circles present a higher association between metabolite
and predictor. P-values were calculated by linear regression models with the milk compound
as independent variable, adjusted for infant sex, and the infant’s age at blood withdrawal. Ran-
dom intercepts were modelled for batch number and study centre. P-values were corrected
(PLME) for multiple testing using Bonferroni’s methods, this is by dividing the p-value with
number of metabolites (n = 184).
(TIFF)
S2 Fig. Inter-Correlations between breast milk fatty acids percentages at 1 month after
birth (a) 4 months after birth (b). Spearman correlation coefficients are plotted for fatty acid-
percentage-fatty-acid-percentage correlation.
(TIFF)
S1 Table. Associations/Correlations between breast milk macronutrient classes (fat and
protein) to infant serum metabolites at 4 months of age. Breast milk components were mea-
sured at month 1 or month 4. Spearman correlation (S) was performed to assess correlation.
Correlations coefficients (R), P-values (P) and number of observation (N) are presented for S.
Associations were calculated by linear regression models (LM) with the milk compound as
independent variable, adjusted for infant sex, breastfeeding status at 4 blood withdrawal
(exclusively BF yes/no), and the infant’s age at blood withdrawal. Random intercepts were
modelled for batch number and study centre. Estimates (B), P-values (P) and number of obser-
vation (N) are presented for the LM. P-values of S and LM were further corrected for multiple
testing using Bonferroni’s methods (Padj), this is by dividing the p-value with number of
metabolites (n = 184).
AA, amino acids; Carn, acylcarnitines; LPC, lysophosphatidylcholines; PC aa, diacyl-phospha-
tidylcholines; PC ae, acyl-alkyl-phosphatidylcholines SM, sphingomyelins.
(XLSX)
S2 Table. Associations/Correlations between breast milk fatty acid percentage to infant
serum metabolites at 4 months of age. Breast milk components were measured at month 1
(a) or month 4 (b). Spearman correlation (“Spearman” sheets) was performed to assess correla-
tion. Correlations coefficients (R) and P-values (are presented for S. Associations were calcu-
lated by linear regression models (“LME sheets”) with the milk fatty acid percentage as
independent variable, adjusted for infant sex, breastfeeding status at 4 blood withdrawal
(exclusively BF yes/no), and the infant’s age at blood withdrawal. Random intercepts were
modelled for batch number and study centre. Estimates (beta) and P-values (p) are presented
for the LME.
AA, amino acids; Carn, acylcarnitines; LPC, lysophosphatidylcholines; PC aa, diacyl-phospha-
tidylcholines; PC ae, acyl-alkyl-phosphatidylcholines SM, sphingomyelins.
(XLSX)
S3 Table. Associations/Correlations between breast milk hormones (adiponectin, IGF-II,
insulin and leptin) to infant serum metabolites at 4 months of age. Breast milk components
were measured at month 1 or month 4. Spearman correlation (S) was performed to assess cor-
relation. Correlations coefficients (R), P-values (P) and number of observation (N) are pre-
sented for S. Associations were calculated by linear regression models (LM) with the milk
compound as independent variable, adjusted for infant sex, breastfeeding status at 4 blood
withdrawal (exclusively BF yes/no), and the infant’s age at blood withdrawal. Random inter-
cepts were modelled for batch number and study centre. Estimates (B), P-values (P) and
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number of observation (N) are presented for the LM. P-values of S and LM were further cor-
rected for multiple testing using Bonferroni’s methods (Padj), this is by dividing the p-value
with number of metabolites (n = 184).
AA, amino acids; Carn, acylcarnitines; LPC, lysophosphatidylcholines; PC aa, diacyl-phospha-
tidylcholines; PC ae, acyl-alkyl-phosphatidylcholines SM, sphingomyelins.
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S1 File. Protocol of the PreventCD trial as outlined in the 6th framework programme, con-
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